Effects of HTEA ON Heart Failure Secondary to Idiopathic Dilated Cardiomyopathy or Post-myocardial Infarction
Overview
- Phase
- Not Applicable
- Sponsor
- Harbin Medical University
- Enrollment
- 60
- Locations
- 2
- Primary Endpoint
- Morbidity
Overview
Brief Summary
The investigators would evaluate the effects of the novel method, HTEA on cardiac function in the heart failure patients secondary to idiopathic dilated cardiomyopathy and post-myocardial infarction.
Detailed Description
The investigators would evaluate the effects of the novel method, HTEA on cardiac function in the heart failure patients secondary to idiopathic dilated cardiomyopathy and post-myocardial infarction. The specific index is 6 miniutes walk distance, echocardiography, NYHA, NTproBNP level, peripherial WBC, RBC, PLT, Cre, UA, K+, Na+ upon entrance to hospital and 4 weeks after HTEA treatment, and 3 months after discharge. The morbidity and re-hospitalization would also calculated 3 months after discharge.
Study Design
- Study Type
- Observational
- Observational Model
- Case Only
- Time Perspective
- Prospective
Eligibility Criteria
- Ages
- 20 Years to 80 Years (Adult, Older Adult)
- Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- •90 chronic cardiac failure patients in our hospital were selected and divided into two groups.
Exclusion Criteria
- •Vavular diseases
Arms & Interventions
idiopathic dilated cardiomyopathy group
idiopathic dilated cardiomyopathy group treated with HTEA
Intervention: HTEA (Drug)
post-myocardial infarction group
post-myocardial infarction group treated with TEA
Intervention: HTEA (Drug)
Outcomes
Primary Outcomes
Morbidity
Time Frame: 1 months to 3 months after discharge
Secondary Outcomes
- The decreased degree of NT-proBNP higher than 30%(3 months after discharge)
Investigators
Wei Liu
Prof. Liu
Harbin Medical University